Skip to main content

Skip to main content

Site Search

Investors Home

Event Details

Investors Home

Puma Biotechnology Update on Alisertib License Agreement

September 20, 2022 5:00 PM ET

Webcast (opens in new window)
Presentation (opens in new window)

Conference Call

Quick Links

SEC Filings
Investor FAQs
Information Request Form

Contact Us

Mariann Ohanesian
Puma Biotechnology

424-248-6500
ir@pumabiotechnology.com

David Schull
Russo Partners, LLC

david.schull@russopartnersllc.com

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Puma Biotechnology, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Puma Biotechnology, Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options *

News

Events & Presentations

Quarterly Reports

Annual Reports

SEC Filings

End of Day Stock Quote



Enter the code shown above.
*

Unsubscribe

Email Alert Sign Up Confirmation

Privacy Policy
Legal Notice
Site Map

© Puma Biotechnology, Inc. - All rights reserved

Powered By Q4 Inc. 5.171.3.2 (opens in new window)